A Study of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy for Patients With KRAS Positive or Squamous Cell Non-Small Cell Lung Cancer

Investigative Site: #34, Pittsburgh

Investigative Site: # 59, Pittsburgh

Investigative Site: #40, Blacksburg

Investigative Site: #53, Newnan

Investigative Site: #56, Savannah

Investigative Site: #46, Fort Meyers

Investigative Site: #35, Zion

Investigative Site: #42, Dallas

Investigative Site: 38, Dallas

Investigative Site: #39, Amarillo

Investigative Site: #44, Phoenix

Investigative Site: #51, Chandler

Investigative Site: #30, Goodyear

Investigative Site: #41, Sedona

Investigative Site: #36, Las Vegas

Investigative Site: #32, Los Angeles

Investigative Site: #58, Duarte

Investigative Site: #47, La Jolla

Investigative Site: #50, San Francisco

Investigative Site: #60, Portland

Investigative Site: #45, Vancouver

Investigative Site: #37, Yakima

Investigative Site: #70, Moscow

Investigative Site: #75, Istra Settle.

Investigative Site: #74, Arkhangelsk

Investigative Site: #76, Saint Petersburg

Investigative Site: #71, Saint Petersburg

Investigative Site: #73, Saint Petersburg

Investigative Site: #77, Saint Petersburg

Investigative Site: #78, Kazan'

Investigative Site: #72, Ufa

Investigative Site: #79, Rostov-on-Don